Literature DB >> 21172233

Pneumonia due to Nocardia cyriacigeorgica in a patient with Crohn's disease treated with infliximab.

M I Parra1, M C Martinez, M A Remacha, J A Saéz-Nieto, E Garcia, G Yagüe, J Guardiola.   

Abstract

Infliximab, an anti-tumor necrosis factor α (TNF-α) antibody, is useful in the treatment of rheumatoid arthritis, Crohn's disease etc. It has been related to increases in the rate of several infections. We present the case of a 53-year-old woman diagnosed with community-acquired pneumonia due to Nocardia cyriacigeorgica who was taking infliximab, azathioprine and prednisone for Crohn's disease.

Entities:  

Year:  2008        PMID： 21172233     DOI： 10.1016/j.crohns.2008.05.003

Source DB:  PubMed          Journal:  J Crohns Colitis        ISSN： 1873-9946            Impact factor:   9.071


  3 in total

Review 1.  Nocardia infections among immunomodulated inflammatory bowel disease patients: A review.

Authors:  Cândida Abreu; Nuno Rocha-Pereira; António Sarmento; Fernando Magro
Journal:  World J Gastroenterol       Date:  2015-06-07       Impact factor: 5.742

2.  Pulmonary nocardiosis in an adolescent patient with Crohn's disease treated with infliximab: a serious complication of TNF-alpha blockers.

Authors:  Rishi Verma; Ritu Walia; Stephen B Sondike; Raheel Khan
Journal:  W V Med J       Date:  2015 May-Jun

3.  Successful resolution of pneumonia developed in a patient affected by Crohn's disease, rheumatoid arthritis, myasthenia gravis and recurrent uveitis during concomitant treatment with tumour necrosis factor alpha inhibitors and conventional immunosuppressive drugs.

Authors:  Erika Angelucci; Monica Cesarini; Piero Vernia
Journal:  Rheumatol Int       Date:  2009-06-24       Impact factor: 2.631
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.